Literature DB >> 21605273

Task-shifting in the delivery of hormonal contraceptive methods: validation of a questionnaire and preliminary results.

Edith Raphaëlle Guilbert1, Diane Morin, Alexis Couture Guilbert, Hélène Gagnon, Jean Robitaille, Mary Richardson.   

Abstract

In order to palliate the access problem to effective contraceptive methods in Quebec, Canada, as well as to legitimate nurses' practices in family planning, a collaborative agreement was developed that allow nurses, in conjunction with pharmacists, to give hormonal contraceptives to healthy women of reproductive age for a 6 month period. Training in hormonal contraception was offered to targeted nurses before they could begin this practice. A questionnaire, based on Rogers's theory of diffusion of innovations, was elaborated and validated to specifically evaluate this phenomenon. Preliminary results show that the translation of training into practice might be suboptimal. The validated questionnaire can now be used to fully understand the set of factors influencing this new practice.
© 2011 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605273     DOI: 10.1111/j.1440-172X.2011.01939.x

Source DB:  PubMed          Journal:  Int J Nurs Pract        ISSN: 1322-7114            Impact factor:   2.066


  3 in total

1.  Barriers and facilitators to family planning access in Canada.

Authors:  Jennifer Hulme; Sheila Dunn; Edith Guilbert; Judith Soon; Wendy Norman
Journal:  Healthc Policy       Date:  2015-02

2.  Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol.

Authors:  Wendy V Norman; Sarah Munro; Melissa Brooks; Courtney Devane; Edith Guilbert; Regina Renner; Tamil Kendall; Judith A Soon; Ashley Waddington; Marie-Soleil Wagner; Sheila Dunn
Journal:  BMJ Open       Date:  2019-04-20       Impact factor: 2.692

3.  Emergency contraception subsidy in Canada: a comparative policy analysis.

Authors:  Sabrina C Lee; Wendy V Norman
Journal:  BMC Health Serv Res       Date:  2022-09-01       Impact factor: 2.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.